Juanni Li

1.1k total citations
39 papers, 814 citations indexed

About

Juanni Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juanni Li has authored 39 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juanni Li's work include Ferroptosis and cancer prognosis (12 papers), Epigenetics and DNA Methylation (9 papers) and MicroRNA in disease regulation (9 papers). Juanni Li is often cited by papers focused on Ferroptosis and cancer prognosis (12 papers), Epigenetics and DNA Methylation (9 papers) and MicroRNA in disease regulation (9 papers). Juanni Li collaborates with scholars based in China, United States and France. Juanni Li's co-authors include Kuan Hu, Zhijie Xu, Yuanliang Yan, Xiaoying Wu, Lei Zhou, Guanghui Gong, Junpu Wang, Ding Zhu, Yixuan Wang and Lei Yao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

In The Last Decade

Juanni Li

39 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juanni Li China 16 605 405 141 112 76 39 814
Sufang Wu China 18 484 0.8× 325 0.8× 85 0.6× 103 0.9× 116 1.5× 39 725
Zezhen Liu China 14 495 0.8× 298 0.7× 200 1.4× 108 1.0× 47 0.6× 26 681
Xiaoling Wu China 21 758 1.3× 543 1.3× 83 0.6× 170 1.5× 79 1.0× 54 996
Peiguo Cao China 18 581 1.0× 496 1.2× 130 0.9× 168 1.5× 55 0.7× 58 878
Wenxing Qin China 17 437 0.7× 283 0.7× 95 0.7× 171 1.5× 95 1.3× 30 780
Shengni Hua China 16 829 1.4× 587 1.4× 122 0.9× 253 2.3× 76 1.0× 22 1.1k
Lu Yue China 17 627 1.0× 234 0.6× 119 0.8× 227 2.0× 71 0.9× 34 866
Geyan Wu China 21 849 1.4× 568 1.4× 160 1.1× 179 1.6× 135 1.8× 29 1.1k
Shiva S. Forootan United Kingdom 15 621 1.0× 394 1.0× 180 1.3× 161 1.4× 48 0.6× 22 838
Yuchao He China 12 393 0.6× 303 0.7× 121 0.9× 112 1.0× 53 0.7× 25 593

Countries citing papers authored by Juanni Li

Since Specialization
Citations

This map shows the geographic impact of Juanni Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juanni Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juanni Li more than expected).

Fields of papers citing papers by Juanni Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juanni Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juanni Li. The network helps show where Juanni Li may publish in the future.

Co-authorship network of co-authors of Juanni Li

This figure shows the co-authorship network connecting the top 25 collaborators of Juanni Li. A scholar is included among the top collaborators of Juanni Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juanni Li. Juanni Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Guo, Kuan Hu, Xiaofang Zhang, Ledu Zhou, & Juanni Li. (2023). Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis. Scientific Reports. 13(1). 4435–4435. 2 indexed citations
2.
Hu, Kuan, Lei Yao, Lei Zhou, & Juanni Li. (2022). Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 3 indexed citations
3.
Fan, Lili, Lei Han, Ying Lin, et al.. (2022). Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis. Cellular and Molecular Life Sciences. 79(5). 254–254. 10 indexed citations
4.
Zhou, Lei, Juanni Li, Yongzhong Tang, et al.. (2022). Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis. Cell Death Discovery. 8(1). 31–31. 7 indexed citations
5.
Hu, Kuan, et al.. (2022). Downregulated PRNP Facilitates Cell Proliferation and Invasion and Has Effect on the Immune Regulation in Ovarian Cancer. Journal of Immunology Research. 2022. 1–11. 9 indexed citations
6.
Zhou, Lei, Juanni Li, Xiaofang Zhang, et al.. (2022). An integrative pan cancer analysis of RET aberrations and their potential clinical implications. Scientific Reports. 12(1). 13913–13913. 10 indexed citations
7.
Li, Juanni, et al.. (2021). Prognostic Value of PLXND1 and TGF-β1 Coexpression and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 604131–604131. 13 indexed citations
8.
Yan, Yuanliang, Yuan Cai, Bi Peng, et al.. (2021). ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis. Frontiers in Cell and Developmental Biology. 9. 633927–633927. 21 indexed citations
9.
Zhou, Zhiyang, Bi Peng, Juanni Li, et al.. (2021). Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications. Scientific Reports. 11(1). 18366–18366. 3 indexed citations
10.
Cai, Yuan, Kewa Gao, Bi Peng, et al.. (2021). Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer. Frontiers in Pharmacology. 12. 781033–781033. 36 indexed citations
11.
Cai, Yuan, Bi Peng, Juanni Li, et al.. (2021). Expression and molecular profiles of the AlkB family in ovarian serous carcinoma. Aging. 13(7). 9679–9692. 30 indexed citations
12.
Tan, Fengbo, Kuan Hu, Dong Wang, et al.. (2020). <p>WAVE2 Enhanced Hepatic Stellate Cells Activity in Colorectal Liver Metastases</p>. Cancer Management and Research. Volume 12. 7671–7680. 5 indexed citations
13.
Li, Juanni, Ayesha B. Alvero, Sudhakar V. Nuti, et al.. (2020). CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential. Oncogene. 39(20). 3965–3979. 28 indexed citations
14.
Li, Juanni, Kuan Hu, Lei Zhou, et al.. (2020). Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis. Frontiers in Oncology. 10. 560615–560615. 9 indexed citations
15.
Zhang, Kexin, et al.. (2019). Effect of acute exposure to hypobaric hypoxia on learning and memory in adult Sprague-Dawley rats. Behavioural Brain Research. 367. 82–90. 11 indexed citations
16.
Luo, Jia, Dong Wang, Sai Zhang, et al.. (2019). BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage. Journal of Cancer. 10(18). 4293–4304. 14 indexed citations
17.
Hu, Kuan, et al.. (2018). CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage. Translational Oncology. 11(2). 552–558. 36 indexed citations
18.
Li, Juanni, Long Li, Zexia Li, et al.. (2015). The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion. Gynecologic Oncology. 137(1). 125–133. 52 indexed citations
19.
Zhou, Jun, Ming Xie, Yongyong Shi, et al.. (2015). MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells. Oncology Reports. 34(1). 111–120. 39 indexed citations
20.
Tan, Hong, Qingnan He, Yixuan Wang, et al.. (2015). miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. International Journal of Oncology. 48(1). 181–190. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sufang Wu Breakdown of academic impact, for papers by Zezhen Liu Breakdown of academic impact, for papers by Xiaoling Wu Breakdown of academic impact, for papers by Peiguo Cao Breakdown of academic impact, for papers by Wenxing Qin Breakdown of academic impact, for papers by Shengni Hua Breakdown of academic impact, for papers by Lu Yue Breakdown of academic impact, for papers by Geyan Wu Breakdown of academic impact, for papers by Shiva S. Forootan Breakdown of academic impact, for papers by Yuchao He
Rankless by CCL
2026